Platelet calcium signaling by G-protein coupled and ITAM-linked receptors regulating anoctamin-6 and procoagulant activity
DI Fernández, MJE Kuijpers, JWM Heemskerk - Platelets, 2021 - Taylor & Francis
Most agonists stimulate platelet Ca2+ rises via G-protein coupled receptors (GPCRs) or
ITAM-linked receptors (ILRs). Well studied are the GPCRs stimulated by the soluble agonists …
ITAM-linked receptors (ILRs). Well studied are the GPCRs stimulated by the soluble agonists …
The predominant PAR4 variant in individuals of African ancestry worsens murine and human stroke outcomes
Protease-activated receptor 4 (PAR4)(gene F2RL3) harbors a functional dimorphism,
rs773902 A/G (encoding Thr120/Ala120, respectively) and is associated with greater platelet …
rs773902 A/G (encoding Thr120/Ala120, respectively) and is associated with greater platelet …
GPR56/ADGRG1 is a platelet collagen-responsive GPCR and hemostatic sensor of shear force
Circulating platelets roll along exposed collagen at vessel injury sites and respond with
filipodia protrusion, shape change, and surface area expansion to facilitate platelet …
filipodia protrusion, shape change, and surface area expansion to facilitate platelet …
The domino effect triggered by the tethered ligand of the protease activated receptors
X Han, MT Nieman - Thrombosis research, 2020 - Elsevier
Protease activated receptors (PARs) are G-protein coupled receptors (GPCRs) that have a
unique activation mechanism. Unlike other GPCRs that can be activated by free ligands …
unique activation mechanism. Unlike other GPCRs that can be activated by free ligands …
[HTML][HTML] DHA 12‐LOX‐derived oxylipins regulate platelet activation and thrombus formation through a PKA‐dependent signaling pathway
Background The effects of docosahexaenoic acid (DHA) on cardiovascular disease are
controversial and a mechanistic understanding of how this omega‐3 polyunsaturated fatty …
controversial and a mechanistic understanding of how this omega‐3 polyunsaturated fatty …
Species differences in platelet protease-activated receptors
SA Renna, SE McKenzie, JV Michael - International Journal of Molecular …, 2023 - mdpi.com
Protease-activated receptors (PARs) are a class of integral membrane proteins that are
cleaved by a variety of proteases, most notably thrombin, to reveal a tethered ligand and …
cleaved by a variety of proteases, most notably thrombin, to reveal a tethered ligand and …
Using PAR4 inhibition as an anti-thrombotic approach: why, how, and when?
S Li, V Tarlac, JR Hamilton - International journal of molecular sciences, 2019 - mdpi.com
Protease-activated receptors (PARs) are a family of four GPCRs with a variety of cellular
functions, yet the only advanced clinical endeavours to target these receptors for therapeutic …
functions, yet the only advanced clinical endeavours to target these receptors for therapeutic …
Epigenetic Regulation of F2RL3 Associates With Myocardial Infarction and Platelet Function
Background: DNA hypomethylation at the F2RL3 (F2R like thrombin or trypsin receptor 3)
locus has been associated with both smoking and atherosclerotic cardiovascular disease; …
locus has been associated with both smoking and atherosclerotic cardiovascular disease; …
Recent insights into the regulation of coagulation and thrombosis
X Li, MMS Sim, JP Wood - Arteriosclerosis, thrombosis, and …, 2020 - Am Heart Assoc
Although procoagulant TF is clearly expressed in the vascular subendothelium, it has also
been proposed that many different cell types express an inactive, encrypted form of TF that …
been proposed that many different cell types express an inactive, encrypted form of TF that …
[HTML][HTML] Observational Analyses of Ex Vivo Native American Platelet Responses
K Goerger, M Caldwell, G Biermann, F Besh… - International Journal of …, 2024 - mdpi.com
Platelet activation plays an essential role in clot formation to prevent blood loss following
vascular damage. In pathologic conditions, platelet activation can lead to obstructive clots …
vascular damage. In pathologic conditions, platelet activation can lead to obstructive clots …